BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Clossen BL, Reddy DS. Novel therapeutic approaches for disease-modification of epileptogenesis for curing epilepsy. Biochim Biophys Acta Mol Basis Dis 2017;1863:1519-38. [PMID: 28179120 DOI: 10.1016/j.bbadis.2017.02.003] [Cited by in Crossref: 44] [Cited by in F6Publishing: 39] [Article Influence: 8.8] [Reference Citation Analysis]
Number Citing Articles
1 Lumley L, Niquet J, Marrero-Rosado B, Schultz M, Rossetti F, de Araujo Furtado M, Wasterlain C. Treatment of acetylcholinesterase inhibitor-induced seizures with polytherapy targeting GABA and glutamate receptors. Neuropharmacology 2021;185:108444. [PMID: 33359073 DOI: 10.1016/j.neuropharm.2020.108444] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
2 Yimer EM, Surur A, Wondafrash DZ, Gebre AK. The Effect of Metformin in Experimentally Induced Animal Models of Epileptic Seizure. Behav Neurol 2019;2019:6234758. [PMID: 30863464 DOI: 10.1155/2019/6234758] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 3.7] [Reference Citation Analysis]
3 Lourenço DM, Ribeiro-Rodrigues L, Sebastião AM, Diógenes MJ, Xapelli S. Neural Stem Cells and Cannabinoids in the Spotlight as Potential Therapy for Epilepsy. Int J Mol Sci 2020;21:E7309. [PMID: 33022963 DOI: 10.3390/ijms21197309] [Reference Citation Analysis]
4 Kumar R, Arora R, Sarangi SC, Ganeshan N S, Agarwal A, Kaleekal T, Gupta YK. Pharmacodynamic and pharmacokinetic interactions of hydroalcoholic leaf extract of Centella asiatica with valproate and phenytoin in experimental models of epilepsy in rats. J Ethnopharmacol 2021;270:113784. [PMID: 33429032 DOI: 10.1016/j.jep.2021.113784] [Reference Citation Analysis]
5 Golub V, Reddy DS. Cannabidiol Therapy for Refractory Epilepsy and Seizure Disorders. Adv Exp Med Biol 2021;1264:93-110. [PMID: 33332006 DOI: 10.1007/978-3-030-57369-0_7] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 5.0] [Reference Citation Analysis]
6 Marrero-Rosado BM, de Araujo Furtado M, Kundrick ER, Walker KA, Stone MF, Schultz CR, Nguyen DA, Lumley LA. Ketamine as adjunct to midazolam treatment following soman-induced status epilepticus reduces seizure severity, epileptogenesis, and brain pathology in plasma carboxylesterase knockout mice. Epilepsy Behav 2020;111:107229. [PMID: 32575012 DOI: 10.1016/j.yebeh.2020.107229] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
7 Wu X, Muthuchamy M, Reddy DS. Atomic force microscopy investigations of fibronectin and α5β1-integrin signaling in neuroplasticity and seizure susceptibility in experimental epilepsy. Epilepsy Research 2017;138:71-80. [DOI: 10.1016/j.eplepsyres.2017.10.013] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.2] [Reference Citation Analysis]
8 Gordo G, Tenorio J, Arias P, Santos-Simarro F, García-Miñaur S, Moreno JC, Nevado J, Vallespin E, Rodriguez-Laguna L, de Mena R, Dapia I, Palomares-Bralo M, Del Pozo Á, Ibañez K, Silla JC, Barroso E, Ruiz-Pérez VL, Martinez-Glez V, Lapunzina P. mTOR mutations in Smith-Kingsmore syndrome: Four additional patients and a review. Clin Genet 2018;93:762-75. [PMID: 28892148 DOI: 10.1111/cge.13135] [Cited by in Crossref: 20] [Cited by in F6Publishing: 20] [Article Influence: 5.0] [Reference Citation Analysis]
9 Chuang SH, Reddy DS. 3β-Methyl-Neurosteroid Analogs Are Preferential Positive Allosteric Modulators and Direct Activators of Extrasynaptic δ-Subunit γ-Aminobutyric Acid Type A Receptors in the Hippocampus Dentate Gyrus Subfield. J Pharmacol Exp Ther 2018;365:583-601. [PMID: 29602830 DOI: 10.1124/jpet.117.246660] [Cited by in Crossref: 16] [Cited by in F6Publishing: 13] [Article Influence: 4.0] [Reference Citation Analysis]
10 Wilcox KS, West PJ, Metcalf CS. The current approach of the Epilepsy Therapy Screening Program contract site for identifying improved therapies for the treatment of pharmacoresistant seizures in epilepsy. Neuropharmacology 2020;166:107811. [PMID: 31790717 DOI: 10.1016/j.neuropharm.2019.107811] [Cited by in Crossref: 25] [Cited by in F6Publishing: 17] [Article Influence: 8.3] [Reference Citation Analysis]
11 Tescarollo FC, Rombo DM, DeLiberto LK, Fedele DE, Alharfoush E, Tomé ÂR, Cunha RA, Sebastião AM, Boison D. Role of Adenosine in Epilepsy and Seizures. J Caffeine Adenosine Res 2020;10:45-60. [PMID: 32566903 DOI: 10.1089/caff.2019.0022] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 4.0] [Reference Citation Analysis]
12 Reddy DS, Yoshimura RF, Ramanathan G, Carver C, Johnstone TB, Hogenkamp DJ, Gee KW. Role of β 2/3 -specific GABA-A receptor isoforms in the development of hippocampus kindling epileptogenesis. Epilepsy & Behavior 2018;82:57-63. [DOI: 10.1016/j.yebeh.2018.02.020] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
13 Rosal Lustosa Í, Soares JI, Biagini G, Lukoyanov NV. Neuroplasticity in Cholinergic Projections from the Basal Forebrain to the Basolateral Nucleus of the Amygdala in the Kainic Acid Model of Temporal Lobe Epilepsy. Int J Mol Sci 2019;20:E5688. [PMID: 31766245 DOI: 10.3390/ijms20225688] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
14 French JA, Bebin M, Dichter MA, Engel J Jr, Hartman AL, Jóźwiak S, Klein P, McNamara J Sr, Twyman R, Vespa P. Antiepileptogenesis and disease modification: Clinical and regulatory issues. Epilepsia Open 2021;6:483-92. [PMID: 34270884 DOI: 10.1002/epi4.12526] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
15 Yu N, Lin XJ, Di Q. How to Find Candidate Drug-targets for Antiepileptogenic Therapy? Curr Neuropharmacol 2020;18:624-35. [PMID: 31989901 DOI: 10.2174/1570159X18666200128124338] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
16 Reddy DS, Wu X, Golub VM, Dashwood WM, Dashwood RH. Measuring Histone Deacetylase Inhibition in the Brain. Curr Protoc Pharmacol 2018;81:e41. [PMID: 29927058 DOI: 10.1002/cpph.41] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 2.8] [Reference Citation Analysis]
17 Löscher W. The holy grail of epilepsy prevention: Preclinical approaches to antiepileptogenic treatments. Neuropharmacology 2020;167:107605. [PMID: 30980836 DOI: 10.1016/j.neuropharm.2019.04.011] [Cited by in Crossref: 34] [Cited by in F6Publishing: 30] [Article Influence: 11.3] [Reference Citation Analysis]
18 de Almeida da Anunciação AR, Favaron PO, de Morais-Pinto L, de Carvalho CMF, Dos Santos Martins D, Conei D, Del Sol M, Vásquez B, Miglino MA. Central nervous system development in rabbits (Oryctolagus cuniculus L. 1758). Anat Rec (Hoboken) 2021;304:1313-28. [PMID: 33480146 DOI: 10.1002/ar.24586] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
19 Bojja SL, Medhi B, Anand S, Bhatia A, Joshi R, Minz RW. Metformin ameliorates the status epilepticus- induced hippocampal pathology through possible mTOR modulation. Inflammopharmacology 2021;29:137-51. [PMID: 33386490 DOI: 10.1007/s10787-020-00782-8] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
20 Löscher W, Klein P. New approaches for developing multi-targeted drug combinations for disease modification of complex brain disorders. Does epilepsy prevention become a realistic goal? Pharmacol Ther 2021;:107934. [PMID: 34216705 DOI: 10.1016/j.pharmthera.2021.107934] [Reference Citation Analysis]
21 Sun M, McDonald SJ, Brady RD, Collins-Praino L, Yamakawa GR, Monif M, O'Brien TJ, Cloud GC, Sobey CG, Mychasiuk R, Loane DJ, Shultz SR. The need to incorporate aged animals into the preclinical modeling of neurological conditions. Neurosci Biobehav Rev 2020;109:114-28. [PMID: 31877345 DOI: 10.1016/j.neubiorev.2019.12.027] [Cited by in Crossref: 17] [Cited by in F6Publishing: 14] [Article Influence: 5.7] [Reference Citation Analysis]
22 Chuang SH, Reddy DS. Zinc reduces antiseizure activity of neurosteroids by selective blockade of extrasynaptic GABA-A receptor-mediated tonic inhibition in the hippocampus. Neuropharmacology 2019;148:244-56. [PMID: 30471294 DOI: 10.1016/j.neuropharm.2018.11.031] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
23 Cacabelos R. Epigenetics and Pharmacoepigenetics of Neurodevelopmental and Neuropsychiatric Disorders. Pharmacoepigenetics. Elsevier; 2019. pp. 609-709. [DOI: 10.1016/b978-0-12-813939-4.00022-x] [Cited by in Crossref: 2] [Article Influence: 0.7] [Reference Citation Analysis]
24 Löscher W. Single-Target Versus Multi-Target Drugs Versus Combinations of Drugs With Multiple Targets: Preclinical and Clinical Evidence for the Treatment or Prevention of Epilepsy. Front Pharmacol 2021;12:730257. [PMID: 34776956 DOI: 10.3389/fphar.2021.730257] [Reference Citation Analysis]
25 Binder DK, Steinhäuser C. Astrocytes and Epilepsy. Neurochem Res 2021. [PMID: 33661442 DOI: 10.1007/s11064-021-03236-x] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
26 Sawicka KM, Florek-Łuszczki M, Wawryniuk A, Daniluk J, Wróblewska-Łuczka P, Chmielewski J, Karwan S, Łuszczki JJ. Dronedarone (a multichannel blocker) enhances the anticonvulsant potency of lamotrigine, but not that of lacosamide, pregabalin and topiramate in the tonic-clonic seizure model in mice. Epilepsy Res 2019;154:62-8. [PMID: 31059963 DOI: 10.1016/j.eplepsyres.2019.04.007] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
27 Peterson AR, Binder DK. Astrocyte Glutamate Uptake and Signaling as Novel Targets for Antiepileptogenic Therapy. Front Neurol 2020;11:1006. [PMID: 33013665 DOI: 10.3389/fneur.2020.01006] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 7.0] [Reference Citation Analysis]
28 Tilelli CQ, Flôres LR, Cota VR, Castro OW, Garcia-Cairasco N. Amygdaloid complex anatomopathological findings in animal models of status epilepticus. Epilepsy Behav 2021;121:106831. [PMID: 31864944 DOI: 10.1016/j.yebeh.2019.106831] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
29 Golub VM, Reddy DS. Contusion brain damage in mice for modelling of post-traumatic epilepsy with contralateral hippocampus sclerosis: Comprehensive and longitudinal characterization of spontaneous seizures, neuropathology, and neuropsychiatric comorbidities. Exp Neurol 2021;348:113946. [PMID: 34896334 DOI: 10.1016/j.expneurol.2021.113946] [Reference Citation Analysis]
30 Jha M, Alam O, Naim MJ, Sharma V, Bhatia P, Sheikh AA, Nawaz F, Alam P, Manaithiya A, Kumar V, Nazar S, Siddiqui N. Recent advancement in the discovery and development of anti-epileptic biomolecules: An insight into structure activity relationship and Docking. Eur J Pharm Sci 2020;153:105494. [PMID: 32730845 DOI: 10.1016/j.ejps.2020.105494] [Reference Citation Analysis]
31 Reddy SD, Clossen BL, Reddy DS. Epigenetic Histone Deacetylation Inhibition Prevents the Development and Persistence of Temporal Lobe Epilepsy. J Pharmacol Exp Ther 2017;364:97-109. [DOI: 10.1124/jpet.117.244939] [Cited by in Crossref: 20] [Cited by in F6Publishing: 20] [Article Influence: 4.0] [Reference Citation Analysis]
32 Obese E, Biney RP, Henneh IT, Adakudugu EA, Anokwah D, Agyemang LS, Woode E, Ameyaw EO. The Anticonvulsant Effect of Hydroethanolic Leaf Extract of Calotropis procera (Ait) R. Br. (Apocynaceae). Neural Plast 2021;2021:5566890. [PMID: 34257639 DOI: 10.1155/2021/5566890] [Reference Citation Analysis]
33 Ugur Yilmaz C, Emik S, Orhan N, Temizyurek A, Atis M, Akcan U, Khodadust R, Arican N, Kucuk M, Gurses C, Ahishali B, Kaya M. Targeted delivery of lacosamide-conjugated gold nanoparticles into the brain in temporal lobe epilepsy in rats. Life Sciences 2020;257:118081. [DOI: 10.1016/j.lfs.2020.118081] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
34 Lalwani AM, Yilmaz A, Bisgin H, Ugur Z, Akyol S, Graham SF. The Biochemical Profile of Post-Mortem Brain from People Who Suffered from Epilepsy Reveals Novel Insights into the Etiopathogenesis of the Disease. Metabolites 2020;10:E261. [PMID: 32585915 DOI: 10.3390/metabo10060261] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
35 Pototskiy E, Dellinger JR, Bumgarner S, Patel J, Sherrerd-Smith W, Musto AE. Brain injuries can set up an epileptogenic neuronal network. Neurosci Biobehav Rev 2021:S0149-7634(21)00346-8. [PMID: 34384843 DOI: 10.1016/j.neubiorev.2021.08.003] [Reference Citation Analysis]
36 Reddy SD, Younus I, Sridhar V, Reddy DS. Neuroimaging Biomarkers of Experimental Epileptogenesis and Refractory Epilepsy. Int J Mol Sci 2019;20:E220. [PMID: 30626103 DOI: 10.3390/ijms20010220] [Cited by in Crossref: 15] [Cited by in F6Publishing: 12] [Article Influence: 5.0] [Reference Citation Analysis]
37 Labh R, Gupta R, Narang M, Halder S, Kar R. Effect of valproate and add-on levetiracetam on inflammatory biomarkers in children with epilepsy. Epilepsy Behav 2021;125:108358. [PMID: 34717170 DOI: 10.1016/j.yebeh.2021.108358] [Reference Citation Analysis]
38 Citraro R, Leo A, De Caro C, Nesci V, Gallo Cantafio ME, Amodio N, Mattace Raso G, Lama A, Russo R, Calignano A, Tallarico M, Russo E, De Sarro G. Effects of Histone Deacetylase Inhibitors on the Development of Epilepsy and Psychiatric Comorbidity in WAG/Rij Rats. Mol Neurobiol 2020;57:408-21. [PMID: 31368023 DOI: 10.1007/s12035-019-01712-8] [Cited by in Crossref: 23] [Cited by in F6Publishing: 18] [Article Influence: 7.7] [Reference Citation Analysis]
39 Ramandi D, Elahdadi Salmani M, Moghimi A, Lashkarbolouki T, Fereidoni M. Pharmacological upregulation of GLT-1 alleviates the cognitive impairments in the animal model of temporal lobe epilepsy. PLoS One 2021;16:e0246068. [PMID: 33507976 DOI: 10.1371/journal.pone.0246068] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
40 Ramos AB, Cruz RA, Villemarette-Pittman NR, Olejniczak PW, Mader EC Jr. Dexamethasone as Abortive Treatment for Refractory Seizures or Status Epilepticus in the Inpatient Setting. J Investig Med High Impact Case Rep 2019;7:2324709619848816. [PMID: 31104535 DOI: 10.1177/2324709619848816] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
41 Mishra NK, Engel J Jr, Liebeskind DS, Sharma VK, Hirsch LJ, Kasner SE, French JA, Devinsky O, Friedman A, Dawson J, Quinn TJ, Selim M, de Havenon A, Yasuda CL, Cendes F, Benninger F, Zaveri HP, Burneo JG, Srivastava P, Bhushan Singh M, Bhatia R, Vishnu VY, Bentes C, Ferro J, Weiss S, Sivaraju A, Kim JA, Galovic M, Gilmore EJ, Pitkänen A, Davis K, Sansing LH, Sheth KN, Paz JT, Singh A, Sheth S, Worrall BB, Grotta JC, Casillas-Espinos PM, Chen Z, Nicolo JP, Yan B, Kwan P; for International Post Stroke Epilepsy Research Consortium (IPSERC). International Post Stroke Epilepsy Research Consortium (IPSERC): A consortium to accelerate discoveries in preventing epileptogenesis after stroke. Epilepsy Behav 2021;127:108502. [PMID: 34968775 DOI: 10.1016/j.yebeh.2021.108502] [Reference Citation Analysis]
42 Cross JH, Lagae L. The concept of disease modification. Eur J Paediatr Neurol 2020;24:43-6. [PMID: 31879224 DOI: 10.1016/j.ejpn.2019.12.005] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
43 Rossi A, Murta V, Auzmendi J, Ramos AJ. Early Gabapentin Treatment during the Latency Period Increases Convulsive Threshold, Reduces Microglial Activation and Macrophage Infiltration in the Lithium-Pilocarpine Model of Epilepsy. Pharmaceuticals (Basel) 2017;10:E93. [PMID: 29182533 DOI: 10.3390/ph10040093] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.4] [Reference Citation Analysis]